Tirzepatide studies: 457 papers with results
Page 6 of 10
- Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measurement of Body Composition Among Adults With Overweight or Obesity With or Without Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.
Wachiraphansakul N · Diabetes, obesity & metabolism · 2026
Systematic review · 24 results
- Efficacy of pharmacotherapies in improving liver fibrosis among patients with MASLD and fibrosis stages of F1-F3: systematic review and network meta-analysis.
Sun XY · Journal of translational medicine · 2026
Systematic review · 10 results
- Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hung TH · Human psychopharmacology · 2026
Systematic review · 15 results
- Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.
Acucella GA · Endocrinology, diabetes & metabolism · 2026
Systematic review · 4 results
- Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.
Ciudin A · Diabetes, obesity & metabolism · 2026
Systematic review · 10 results
- Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials.
Zhao S · Internal and emergency medicine · 2026
Systematic review · 5 results
- Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis.
Sebastian SA · Disease-a-month : DM · 2026
Systematic review · 8 results
- Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
Au HCT · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Systematic review · 5 results
- Efficacy and safety of anti-prediabetic drugs in patients with prediabetes: a Bayesian network meta-analysis.
Wu Y · BMC medicine · 2026
Systematic review · 4 results
- Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review.
Pardeshi G · Clinical obesity · 2026
Systematic review · 3 results
- Low-Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non-Diabetic Japanese Adults.
Amioka M · Diabetes, obesity & metabolism · 2026
Non-randomized trial · 11 results
- Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.
Yamaguchi Y · Diabetologia · 2025
Non-randomized trial · 8 results
- Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial.
Ishii H · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
Non-randomized trial · 22 results
- Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
Urva S · Clinical pharmacokinetics · 2021
Non-randomized trial · 5 results
- The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists.
Urva S · Diabetes, obesity & metabolism · 2020
Non-randomized trial · 9 results
- Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys.
Martin JA · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024
Non-randomized trial · 9 results
- Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study.
Wu JY · BMC cardiovascular disorders · 2026
Observational study · 9 results
- Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.
Wu JY · Diabetes research and clinical practice · 2026
Observational study · 10 results
- Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi-institutional propensity score-matched study.
Wu JY · Diabetes, obesity & metabolism · 2025
Observational study · 5 results
- Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults.
Katsura M · Diabetes, obesity & metabolism · 2026
Observational study · 14 results
- Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study.
Krüger N · BMJ (Clinical research ed.) · 2026
Observational study · 7 results
- Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.
Ostrominski JW · Diabetes care · 2026
Observational study · 8 results
- Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study.
Khalil I · Hepatology international · 2026
Observational study · 13 results
- Major adverse cardiovascular and limb events caused by tirzepatide in patients with type 2 diabetes at high cardiovascular risk: A comparison with sitagliptin.
Iwasaki Y · Diabetes research and clinical practice · 2026
Observational study · 4 results
- Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.
Krüger N · JAMA · 2025
Observational study · 5 results
- Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study.
Wu JY · Hepatology international · 2026
Observational study · 4 results
- Comparative clinical outcomes of adults with obstructive sleep apnea and comorbid obesity receiving tirzepatide versus bariatric metabolic surgery: A Multi-Institutional propensity score matched study.
Wu JY · Diabetes research and clinical practice · 2025
Observational study · 4 results
- Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
Wu JY · Journal of the American Heart Association · 2026
Observational study · 4 results
- Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: a multi-institutional propensity score-matched study.
Wu JY · Hepatology international · 2025
Observational study · 4 results
- Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).
Wilson L · Diabetes, obesity & metabolism · 2026
Observational study · 8 results
- Sex-based differences in clinical outcomes among patients with obesity and heart failure with preserved ejection fraction treated with tirzepatide.
Mortada I · Therapeutic advances in cardiovascular disease · 2026
Observational study · 7 results
- Semaglutide vs tirzepatide in patients with obesity and HFpEF: a report from a global federated research network.
Monzo L · ESC heart failure · 2026
Observational study · 8 results
- Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study.
le Roux CW · Journal of endocrinological investigation · 2026
Observational study · 8 results
- Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.
Maruyama F · Diabetes, obesity & metabolism · 2026
Observational study · 4 results
- Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study.
Richards R · JMIR formative research · 2025
Observational study · 12 results
- Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.
Oe Y · Therapeutic advances in endocrinology and metabolism · 2025
Observational study · 8 results
- Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study.
Akturk HK · Journal of diabetes science and technology · 2025
Observational study · 6 results
- Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
Crisafulli S · Annals of internal medicine · 2026
Observational study · 4 results
- Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients.
Chunduri S · Cardiovascular drugs and therapy · 2026
Observational study · 12 results
- Real-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: A prospective study.
Pérez-Pevida B · Clinical nutrition ESPEN · 2026
Observational study · 8 results
- Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World Evidence.
Henney AE · Annals of the American Thoracic Society · 2025
Observational study · 11 results
- Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.
Angelopoulos N · Journal of diabetes and its complications · 2025
Observational study · 13 results
- Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide.
Al Ozairi E · Diabetes, obesity & metabolism · 2026
Observational study · 17 results
- Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies.
Fujihara K · Diabetes, obesity & metabolism · 2024
Observational study · 8 results
- Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes.
Cariou B · Diabetes, obesity & metabolism · 2024
Observational study · 3 results
- Ocular Outcomes with Tirzepatide versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes.
Hong AT · Ophthalmology. Retina · 2026
Observational study · 5 results
- Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study.
Qadeer A · Diabetes & vascular disease research · 2026
Observational study · 14 results
- Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study.
da Silva AMP · Journal of diabetes and its complications · 2026
Observational study · 3 results
- Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes.
Lin CL · Nature communications · 2026
Observational study · 4 results
- Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.
Henney AE · Liver international : official journal of the International Association for the Study of the Liver · 2025
Observational study · 9 results